comparemela.com
Home
Live Updates
NICE recommends Koselugo for the treatment of neurofibromatosis type 1 : comparemela.com
NICE recommends Koselugo for the treatment of neurofibromatosis type 1
Alexion Pharma UK, AstraZeneca’s Rare Disease group, announces the recommendation of its pivotal neurofibromatosis treatment - News - PharmaTimes
Related Keywords
Ireland ,
United Kingdom ,
Sean Richardson ,
Vanessa Martin ,
Astrazeneca ,
Childhood Tumour ,
Nationail Institute For Health ,
Nationail Institute ,
Care Excellence ,
Childhood Tumour Trust ,
,
comparemela.com © 2020. All Rights Reserved.